Market Tracker

03/27 3:09pm ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.7202
Delayed Data
As of 2:54pm ET
 -0.002 / -0.28%
Today’s Change
0.65
Today|||52-Week Range
1.29
+2.89%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.72
Today’s open0.74
Day’s range0.72 - 0.74
Volume418,212
Average volume (3 months)956,725
Market cap$129.4M
Dividend yield--
Data as of 2:54pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)-57.14%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ANTHAnthera Pharmaceutic...-0.20-4.38%
NERVMinerva Neuroscience...-0.08-1.49%
CORICorium International...0.000.00%
RDHLRedhill Biopharma Lt...+0.15+1.12%
Data as of 3:07pm ET, 03/27/2015

Financials

Next reporting dateMay 14, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$0.00
Annual profit (last year)-$18.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientist
Chang Ho Ahn
Chief Executive Officer &
Director
Peter David Suzdak
Corporate headquarters
Rockville, Maryland

Forecasts